US Patent 8008499 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof
Patent 8008499 was granted and assigned to Cornerstone Therapeutics on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+340 characters)
Article
Patent abstract
Disclosed are novel anabaseine derivatives that act as agonists of the α7 nAChR. Also disclosed are pharmaceutical compositions, methods of treating inflammatory conditions, methods of treating CNS disorders, methods for inhibiting cytokine release from mammalian cells and methods for the preparation of the novel compounds.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Daniel Elbaum0
Gregory J. Habgood0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08008499 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof US Patent 8008499 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof
Infobox
Patent Number
080084990
Patent Number
80084990
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080084990
Date of Patent
August 30, 2011
0Patent Application Number
126494630
Date Filed
December 30, 2009
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08008499 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08008499
Date of patent
August 30, 2011
Patent application number
12649463
Date Filed
December 30, 2009
Patent primary examiner
Find more entities like US Patent 8008499 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
